Stock Information
Pulse Biosciences Inc (PLSE)
Ticker Symbol: PLSE
Exchange: NASDAQ
Sector: Health Care
Market Cap: $1,558.65 mil
Piotroski score: 2
PE Ratio: N/A
EPS (TTM): -1.08
Revenue (TTM): $0.01 M
Dividend Yield: N/A%
ROE: -73.46%
Latest News
-
Pulse Biosciences Appoints Liane Teplitsky As Chief Operating Officer And Dr. David Kenigsberg As Chief Medical Officer
Thu, Apr 9, 2026 7:08 AM
-
Pulse Biosciences: Promising Catheter Technology, Weak Risk-Reward For Now
Wed, Apr 8, 2026 11:49 AM
-
12 Health Care Stocks Moving In Tuesday's Intraday Session
Tue, Apr 7, 2026 1:05 PM
-
Pulse Biosciences shares are trading lower. The company announced enrollment of the first patients in its NANOPULSE-AF study evaluating the nPulse Cardiac Catheter System for treating atrial fibrillation.
Tue, Apr 7, 2026 10:21 AM
-
Pulse Biosciences Enrolls First Patient In Its NANOPULSE-AF Study Of nPulse Cardiac Catheter System For Recurrent, Drug-Resistant, Symptomatic Paroxysmal Atrial Fibrillation
Tue, Apr 7, 2026 7:11 AM
Key Financials
Financial data not available
